HSP70/SIRT2-IN-1 (Compound 2a) serves as a dual inhibitor targeting both SIRT2 and HSP70, exhibiting an IC50 of 17.32.0 µM against SIRT2. This compound possesses antitumor activity [1].
Target:
Sirtuin
* VAT and and shipping costs not included. Errors and price changes excepted